Search Results for "Psa Increased After Negative Biopsy"

13:12 EDT 23rd October 2014 | BioPortfolio

Original Source: Management of Rising Prostate-specific Antigen After a Negative Biopsy.

Prostate biopsy remains one of the most commonly performed urologic office procedures. A significant percentage of men with a negative result may have unrecognized disease. Inadequate biopsy strategies or findings of high-grade prostatic intraepithelial neoplasia or atypia increase this likelihood. The term "negative biopsy" may be misleading. Traditional sextant biopsy is inaccurate and extended- or saturation-biopsy protocols miss small cancers. A rising prostate-specific antigen (PSA) after a negative pr...

Matching Channels

Matching News

Argon gets into transjugular liver biopsy market with US Biopsy buy

Argon Medical Devices Inc. acquired privately held Promex Technologies LLC (dba US Biopsy; soft-tissue biopsy).

Random Biopsy on Negative Colposcopy Detects More Disease

Random biopsy at the transformation zone in women in whom cervical lesions could not be visualized on colposcopy detected additional high-grade disease, especially in those positive for HPV 16 or 18. ...

"Liquid Biopsy" Used to Refer to Detection of Any Serum Cancer DNA

I came across the term liquid biopsy in 2010 and posted my first note about the term followed by two more about it (see: Does the New Term "Liquid Biopsy" Make Any Sense?; Rapid Adoption of the Term "...

Single random biopsy ups detection of cervical disease

(HealthDay)—In women with negative colposcopy, a single random biopsy increases detection of high-grade cervical disease, according to a study published online Sept. 8 in Obstetrics & Gynecology.

Prostate cancer: mpMRI and MRI/TRUS fusion in men with negative biopsy

'Low-risk' prostate cancer often not low-risk when targeted biopsy is used

Selection of men for active surveillance for prostate cancer should be based not on the widely used conventional biopsy, but with a new, image-guided targeted prostate biopsy. Researchers found that c...

Biopsy Sciences sells the HydroMARK breast cancer biopsy marker portfolio to Devicor Medical

Minimally invasive surgery firm Devicor Medical Products Inc. purchased the HydroMARK breast biopsy marker technology from Biopsy Sciences LLC (ultrasound visualization).

Enrichment of Highly Abundant Epigenetic Marks from Endometrial Stromal Cells

Chromatrap®, the novel solid-based matrix for chromatin immunoprecipitation (ChIP) assays, available from Porvair Sciences, has been successfully used to isolate high quality chromatin from d...

Matching PubMed Articles

In patients with a previous negative prostate biopsy and a suspicious lesion on MRI, is a 12-core biopsy still necessary in addition to a targeted biopsy?

To evaluate the performance of multiparametric MRI (MP-MRI) in predicting CaP on repeat biopsy; and to compare the cancer detection rates (CDR) of MRI/TRUS fusion-guided biopsy with standard 12-core b...

Utility of Acid-fast staining for detection of mycobacteria in cutaneous granulomatous tissue reactions.

Objectives: Ancillary molecular testing on tissue is available for mycobacterial disease; however, judicious use of highly sensitive tests, such as polymerase chain reaction (PCR) and sequencing, shou...

The diagnostic value of pre-biopsy magnetic resonance imaging for precise detection of clinically localized prostate cancer compared to post-biopsy setting.

A total of 136 patients who underwent radical prostatectomy following histological diagnosis of prostate cancer by transrectal biopsy and 3-Tesla magnetic resonance imaging (MRI) were evaluated. MRI w...

Real-time MRI/US Fusion-guided Biopsy Improves Detection Rates of Prostate Cancer in Pre-biopsied Patients.

Background: According to the guidelines of the European Association of Urology (EAU) on prostate cancer (PCa) in 2013, patients with increasing prostate-specific antigen (PSA) levels, suspicious digit...

AL-Amyloidosis Presenting with Negative Congo Red Staining in the Setting of High Clinical Suspicion: A Case Report.

A histologic diagnosis of amyloidosis requires acquiring tissue containing amyloid fibrils from an affected organ or alternate site. The biopsy site and staining techniques may influence testing accur...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement